Company
OtoNexus
Bringing Objective Insight to the Ear Exam
Also known as OtoNexus Medical Technologies
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Customers
- The OtoNexus platform is being developed for healthcare professionals who evaluate patients with suspected middle-ear conditions, including pediatricians, family medicine clinicians, urgent care clinicians and otolaryngologists.
- Legal name
- OtoNexus Medical Technologies
Record updated 28 September 2026
About
OtoNexus is developing an AI-enabled ultrasound otoscope designed to reduce diagnostic uncertainty, support antibiotic stewardship, and improve clinical decision-making during ear infection evaluations.
Funding snapshot
- Total raised
- $44.5MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $12.9M2022-10-20
Funding rounds
- Round, 2022
- $12.9M2022-10-20, SEC form D sold, 114 investors
- Round, 2021
- $1.9M2021-12-30, SEC form D sold, 21 investors
- Round, 2018
- $19.5M2018-12-31, SEC form D sold, 190 investors
- Round, 2016
- $7.8M2016-12-30, SEC form D sold, 80 investors
- Round, 2015
- $2.2M2015-08-04, SEC form D sold, 54 investors
- Round, 2013
- $50K2013-08-30, SEC form D sold, 2 investors
- Round, 2012
- $150K2012-05-18, SEC form D sold, 2 investors
Products
- Hardware
- OtoNexus ultrasound otoscope